Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Rachel Dopart, Dai Lu, Aron H. Lichtman & Debra A. Kendall. (2018) Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity. Drug Metabolism Reviews 50:1, pages 3-13.
Read now
Read now
Kjell Fuxe, Daniel Marcellino, Dasiel Oscar Borroto-Escuela, Malgorzata Frankowska, Luca Ferraro, Diego Guidolin, Francisco Ciruela & Luigi F. Agnati. (2010) The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor–receptor interactions. Journal of Receptors and Signal Transduction 30:5, pages 272-283.
Read now
Read now
Wolfgang Froestl. (2010) Novel GABAB receptor positive modulators: a patent survey. Expert Opinion on Therapeutic Patents 20:8, pages 1007-1017.
Read now
Read now
Annette Gilchrist. (2008) A perspective on more effective GPCR-targeted drug discovery efforts. Expert Opinion on Drug Discovery 3:4, pages 375-389.
Read now
Read now
TERRY KENAKIN. (2007) Allosteric Agonist Modulators. Journal of Receptors and Signal Transduction 27:4, pages 247-259.
Read now
Read now
Articles from other publishers (66)
Raahul Sharma, Sameek Singh, Zak M. Whiting, Maximilian Molitor, Andrea J. Vernall & Natasha L. Grimsey. (2023) Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias. International Journal of Molecular Sciences 24:7, pages 6406.
Crossref
Crossref
Raudah Lazim, Yoonji Lee, Pratanphorn Nakliang & Sun Choi. 2022. GPCRs as Therapeutic Targets. GPCRs as Therapeutic Targets
424
457
.
Alexios Chatzigoulas & Zoe Cournia. (2021) Rational design of allosteric modulators: Challenges and successes. WIREs Computational Molecular Science 11:6.
Crossref
Crossref
Zhaotong Cong, Li-Nan Chen, Honglei Ma, Qingtong Zhou, Xinyu Zou, Chenyu Ye, Antao Dai, Qing Liu, Wei Huang, Xianqiang Sun, Xi Wang, Peiyu Xu, Lihua Zhao, Tian Xia, Wenge Zhong, Dehua Yang, H. Eric Xu, Yan Zhang & Ming-Wei Wang. (2021) Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor. Nature Communications 12:1.
Crossref
Crossref
Shane D. Hellyer, Shaili Aggarwal, Amy N. Y. Chen, Katie Leach, David J. Lapinsky & Karen J. Gregory. (2020) Development of Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 2 Based on Two Positive Allosteric Modulator Chemotypes. ACS Chemical Neuroscience 11:11, pages 1597-1609.
Crossref
Crossref
Mojca Lunder, Miha Vodnik, Valentina Kubale, Neža Grgurevič, Gregor Majdič & Borut Štrukelj. (2018) Peptide mimetic of N‐terminal ghrelin enhances ghrelin‐induced growth hormone secretion and c‐Fos expression in mice. Journal of Neuroendocrinology 30:12, pages e12656.
Crossref
Crossref
Li-Jun Xue, Xiao-Bei Mao, Li-Li Ren & Xiao-Yuan Chu. (2017) Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma. Cancer Medicine 6:6, pages 1424-1436.
Crossref
Crossref
Thomas M. Frimurer, Franziska Mende, Anne-Sofie Graae, Maja S. Engelstoft, Kristoffer L. Egerod, Rie Nygaard, Lars-Ole Gerlach, Jakob Bondo Hansen, Thue W. Schwartz & Birgitte Holst. (2017)
Model-Based Discovery of Synthetic Agonists for the Zn
2+
-Sensing G-Protein-Coupled Receptor 39 (GPR39) Reveals Novel Biological Functions
. Journal of Medicinal Chemistry 60:3, pages 886-898.
Crossref
Crossref
Andrew D Powell, Gillian Grafton, Alexander Roberts, Shannon Larkin, Nathanael O'Neill, Josephine Palandri, Reka Otvos, Alison J Cooper, Chris Ulens & Nicholas M Barnes. (2016)
Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT
3
A receptor
. British Journal of Pharmacology 173:24, pages 3467-3479.
Crossref
Crossref
Kristin L. Rockwell & Andrew Alt. 2016. Allosterism in Drug Discovery. Allosterism in Drug Discovery
194
219
.
Andrew Alt. (2016) Overview of Critical Parameters for the Design and Execution of a High‐Throughput Screen for Allosteric Ligands. Current Protocols in Pharmacology 74:1.
Crossref
Crossref
A. Alt, A. Pendri, R. L. Bertekap, G. Li, Y. Benitex, M. Nophsker, K. L. Rockwell, N. T. Burford, C. S. Sum, J. Chen, J. J. Herbst, M. Ferrante, A. Hendricson, M. E. Cvijic, R. S. Westphal, J. OConnell, M. Banks, L. Zhang, R. G. Gentles, S. Jenkins, J. Loy & J. E. Macor. (2015) Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors. Journal of Pharmacology and Experimental Therapeutics 356:2, pages 293-304.
Crossref
Crossref
Nuska Tschammer. 2016. Protein Targeting Compounds. Protein Targeting Compounds
185
207
.
Shreoshi Pal Choudhuri, Rona J. Delay & Eugene R. Delay. (2015) L-Amino Acids Elicit Diverse Response Patterns in Taste Sensory Cells: A Role for Multiple Receptors. PLOS ONE 10:6, pages e0130088.
Crossref
Crossref
John A. DeSimone, Grant E. Dubois & Vijay Lyall. 2015. Handbook of Olfaction and Gustation. Handbook of Olfaction and Gustation
665
684
.
Nuska Tschammer. 2015. Protein Targeting Compounds. Protein Targeting Compounds
185
207
.
Cody J. WenthurPatrick R. GentryThomas P. MathewsCraig W. Lindsley. (2014) Drugs for Allosteric Sites on Receptors. Annual Review of Pharmacology and Toxicology 54:1, pages 165-184.
Crossref
Crossref
Kathryn L. Chapman & John B.C. Findlay. (2013) The melanocortin 4 receptor: Oligomer formation, interaction sites and functional significance. Biochimica et Biophysica Acta (BBA) - Biomembranes 1828:2, pages 535-542.
Crossref
Crossref
Edward M. Brown, Steven C. Hebert, Daniela Riccardi & John P. Geibel. 2013. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney
2187
2224
.
Guy Servant & Gwen Rosenberg. 2012. Sweeteners and Sugar Alternatives in Food Technology. Sweeteners and Sugar Alternatives in Food Technology
383
396
.
Olga Mazina, Reet Reinart-Okugbeni, Sergei Kopanchuk & Ago Rinken. (2012) BacMam System for FRET-Based cAMP Sensor Expression in Studies of Melanocortin MC1 Receptor Activation. SLAS Discovery 17:8, pages 1096-1101.
Crossref
Crossref
J. K. Gill, P. Dhankher, T. D. Sheppard, E. Sher & N. S. Millar. (2012) A Series of 7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties. Molecular Pharmacology 81:5, pages 710-718.
Crossref
Crossref
Grant E. DuBoisIndra Prakash. (2012) Non-Caloric Sweeteners, Sweetness Modulators, and Sweetener Enhancers. Annual Review of Food Science and Technology 3:1, pages 353-380.
Crossref
Crossref
Kenjiro Tadagaki, Ralf Jockers & Maud Kamal. (2012) History and Biological Significance of GPCR Heteromerization in the Neuroendocrine System. Neuroendocrinology 95:3, pages 223-231.
Crossref
Crossref
Guy Servant, Catherine Tachdjian, Xiaodong Li & Donald S. Karanewsky. (2011) The sweet taste of true synergy: positive allosteric modulation of the human sweet taste receptor. Trends in Pharmacological Sciences 32:11, pages 631-636.
Crossref
Crossref
Pascal Maurice, Maud Kamal & Ralf Jockers. (2011) Asymmetry of GPCR oligomers supports their functional relevance. Trends in Pharmacological Sciences 32:9, pages 514-520.
Crossref
Crossref
Bertil B. Fredholm, Adriaan P. IJzerman, Kenneth A. Jacobson, Joel Linden & Christa E. Müller. (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update. Pharmacological Reviews 63:1, pages 1-34.
Crossref
Crossref
Stephan Urwyler. (2011) Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives. Pharmacological Reviews 63:1, pages 59-126.
Crossref
Crossref
Neil T. Burford, John Watson, Robert Bertekap & Andrew Alt. (2011) Strategies for the identification of allosteric modulators of G-protein-coupled receptors. Biochemical Pharmacology 81:6, pages 691-702.
Crossref
Crossref
Maud Kamal, Pascal Maurice & Ralf Jockers. (2011) Expanding the Concept of G Protein-Coupled Receptor (GPCR) Dimer Asymmetry towards GPCR-Interacting Proteins. Pharmaceuticals 4:2, pages 273-284.
Crossref
Crossref
Nicola J. Smith, Kirstie A. Bennett & Graeme Milligan. (2011) When simple agonism is not enough: Emerging modalities of GPCR ligands. Molecular and Cellular Endocrinology 331:2, pages 241-247.
Crossref
Crossref
Kenneth A. Jacobson, Zhan-Guo Gao, Anikó Göblyös & Adriaan P. IJzerman. 2011. Pharmacology of Purine and Pyrimidine Receptors. Pharmacology of Purine and Pyrimidine Receptors
187
220
.
S S Mirnaya, E A Pigarova, A V Belyaeva, N G Mokrysheva, A N Tyul'pakov & L Ya Rozhinskaya. (2010) ROL' KAL'TsIY-ChUVSTVITEL'NOGO RETsEPTORA V PODDERZhANII SISTEMY KAL'TsIEVOGO GOMEOSTAZA. Osteoporosis and Bone Diseases 13:3, pages 32-36.
Crossref
Crossref
Nicola J. Smith & Graeme Milligan. (2010) Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes. Pharmacological Reviews 62:4, pages 701-725.
Crossref
Crossref
Jens Halvard Grønlien, Hilde Ween, Kirsten Thorin-Hagene, Steven Cassar, Jinhe Li, Clark A. Briggs, Murali Gopalakrishnan & John Malysz. (2010) Importance of M2–M3 loop in governing properties of genistein at the α7 nicotinic acetylcholine receptor inferred from α7/5-HT3A chimera. European Journal of Pharmacology 647:1-3, pages 37-47.
Crossref
Crossref
Marco De Amici, Clelia Dallanoce, Ulrike Holzgrabe, Christian Tränkle & Klaus Mohr. (2010) Allosteric ligands for G protein-coupled receptors: A novel strategy with attractive therapeutic opportunities. Medicinal Research Reviews 30:3, pages 463-549.
Crossref
Crossref
Aroa Soriano, Marc Vendrell, Sergio Gonzalez, Josefa Mallol, Fernando Albericio, Miriam Royo, Carmen Lluís, Enric I. Canela, Rafael Franco, Antoni Cortés & Vicent Casadó. (2010)
A Hybrid Indoloquinolizidine Peptide as Allosteric Modulator of Dopamine D
1
Receptors
. Journal of Pharmacology and Experimental Therapeutics 332:3, pages 876-885.
Crossref
Crossref
Magalie Rocheville & Stephen L. Garland. (2010) An industrial perspective on positive allosteric modulation as a means to discover safe and selective drugs. Drug Discovery Today: Technologies 7:1, pages e87-e94.
Crossref
Crossref
Jan Jakubík, Alena Randáková, Esam E El-Fakahany & Vladimír Doležal. (2009) Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors. BMC Pharmacology 9:1.
Crossref
Crossref
Vicent Casadó, Antoni Cortés, Josefa Mallol, Kamil Pérez-Capote, Sergi Ferré, Carmen Lluis, Rafael Franco & Enric I. Canela. (2009) GPCR homomers and heteromers: A better choice as targets for drug development than GPCR monomers?. Pharmacology & Therapeutics 124:2, pages 248-257.
Crossref
Crossref
Mike Lee, Sungwon Choi, Gunnel Halldén, Sek Jin Yo, Denise Schichnes & Gregory W. Aponte. (2009)
P2Y5 is a Gα
i
, Gα
12/13
G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion
. American Journal of Physiology-Gastrointestinal and Liver Physiology 297:4, pages G641-G654.
Crossref
Crossref
K. A. Bennett, C. J. Langmead, A. Wise & G. Milligan. (2009) Growth Hormone Secretagogues and Growth Hormone Releasing Peptides Act As Orthosteric Super-Agonists but Not Allosteric Regulators for Activation of the G Protein G o1 by the Ghrelin Receptor. Molecular Pharmacology 76:4, pages 802-811.
Crossref
Crossref
I. Kalatskaya, Y. A. Berchiche, S. Gravel, B. J. Limberg, J. S. Rosenbaum & N. Heveker. (2009) AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties. Molecular Pharmacology 75:5, pages 1240-1247.
Crossref
Crossref
Laura H. Heitman, Rajeshwar Narlawar, Henk de Vries, Milou N. Willemsen, Dieter Wolfram, Johannes Brussee & Adriaan P. IJzerman. (2009) Substituted Terphenyl Compounds as the First Class of Low Molecular Weight Allosteric Inhibitors of the Luteinizing Hormone Receptor. Journal of Medicinal Chemistry 52:7, pages 2036-2042.
Crossref
Crossref
B. Holst, T. M. Frimurer, J. Mokrosinski, T. Halkjaer, K. B. Cullberg, C. R. Underwood & T. W. Schwartz. (2008) Overlapping Binding Site for the Endogenous Agonist, Small-Molecule Agonists, and Ago-allosteric Modulators on the Ghrelin Receptor. Molecular Pharmacology 75:1, pages 44-59.
Crossref
Crossref
Pia C. Jensen & Mette M. Rosenkilde. 2009. Chemokines, Part B. Chemokines, Part B
171
190
.
D. Hoyer & T. Bartfai. 2009. Encyclopedia of Neuroscience. Encyclopedia of Neuroscience
801
810
.
Charles R. Yang & Kjell A. Svensson. (2008) Allosteric modulation of NMDA receptor via elevation of brain glycine and d-serine: The therapeutic potentials for schizophrenia. Pharmacology & Therapeutics 120:3, pages 317-332.
Crossref
Crossref
Thomas M. Bridges & Craig W. Lindsley. (2008) G-Protein-Coupled Receptors: From Classical Modes of Modulation to Allosteric Mechanisms. ACS Chemical Biology 3:9, pages 530-541.
Crossref
Crossref
Clotilde Mannoury la Cour, Chlo? Herbelles, Val?rie Pasteau, Guillaume de Nanteuil & Mark J. Millan. (2008)
Influence of positive allosteric modulators on GABA
B
receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes
. Journal of Neurochemistry 105:2, pages 308-323.
Crossref
Crossref
Sandra Siehler. (2008) Cell-based assays in GPCR drug discovery. Biotechnology Journal 3:4, pages 471-483.
Crossref
Crossref
T P Kenakin. (2008) Pharmacological Onomastics: What's in a name?. British Journal of Pharmacology 153:3, pages 432-438.
Crossref
Crossref
Steven C. Hebert, Daniela Riccardi & John P. Geibel. 2008. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney
1785
1802
.
O. Mnie-Filali, M. El Mansari, H. Scarna, L. Zimmer, C. Sánchez & N. Haddjeri. (2007) L’escitalopram : un inhibiteur sélectif et un modulateur allostérique du transporteur de la sérotonine. L'Encéphale 33:6, pages 965-972.
Crossref
Crossref
Jean-Yves Springael, Eneko Urizar, Sabine Costagliola, Gilbert Vassart & Marc Parmentier. (2007) Allosteric properties of G protein-coupled receptor oligomers. Pharmacology & Therapeutics 115:3, pages 410-418.
Crossref
Crossref
Christopher A. Johnston & David P. Siderovski. (2007) Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights. Molecular Pharmacology 72:2, pages 219-230.
Crossref
Crossref
Thue W. Schwartz & Birgitte Holst. (2007) Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?. Trends in Pharmacological Sciences 28:8, pages 366-373.
Crossref
Crossref
Katie Leach, Patrick M. Sexton & Arthur Christopoulos. (2007) Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology. Trends in Pharmacological Sciences 28:8, pages 382-389.
Crossref
Crossref
Mette M. Rosenkilde, Michael B. Andersen, Rie Nygaard, Thomas M. Frimurer & Thue W. Schwartz. (2007) Activation of the CXCR3 Chemokine Receptor through Anchoring of a Small Molecule Chelator Ligand between TM-III, -IV, and -VI. Molecular Pharmacology 71:3, pages 930-941.
Crossref
Crossref
Lauren T. MayKatie LeachPatrick M. SextonArthur Christopoulos. (2007) Allosteric Modulation of G Protein–Coupled Receptors. Annual Review of Pharmacology and Toxicology 47:1, pages 1-51.
Crossref
Crossref
Lotte Bjerre KnudsenDan KielMin TengCarsten BehrensDilip Bhumralkar, János T. KodraJens J. Holst, Claus B. JeppesenMichael D. JohnsonJohannes Cornelis de JongAnker Steen JorgensenTim Kercher, Jarek Kostrowicki, Peter MadsenPreben H. OlesenJacob S. PetersenFritz PoulsenUlla G. Sidelmann, Jeppe SturisLarry Truesdale, John MayJesper Lau. (2007) Small-molecule agonists for the glucagon-like peptide 1 receptor. Proceedings of the National Academy of Sciences 104:3, pages 937-942.
Crossref
Crossref
Giampiero Muccioli, Alessandra Baragli, Riccarda Granata, Mauro Papotti & Ezio Ghigo. (2007) Heterogeneity of Ghrelin/Growth Hormone Secretagogue Receptors. Neuroendocrinology 86:3, pages 147-164.
Crossref
Crossref
Sungwon Choi, Mike Lee, Amy L. Shiu, Sek Jin Yo & Gregory W. Aponte. (2007) Identification of a protein hydrolysate responsive G protein-coupled receptor in enterocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology 292:1, pages G98-G112.
Crossref
Crossref
Delphine S. Dupuis, Dinko Relkovic, Loic Lhuillier, Johannes Mosbacher & Klemens Kaupmann. (2006)
Point Mutations in the Transmembrane Region of GABA
B2
Facilitate Activation by the Positive Modulator
N,N
′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the Absence of the GABA
B1
Subunit
. Molecular Pharmacology 70:6, pages 2027-2036.
Crossref
Crossref
Juan Ballesteros & John Ransom. (2006) In-Target versus Off-Target allosteric modulators of GPCRs. Drug Discovery Today: Therapeutic Strategies 3:4, pages 445-450.
Crossref
Crossref
Laura Albizu, Marie-Noëlle Balestre, Christophe Breton, Jean-Philippe Pin, Maurice Manning, Bernard Mouillac, Claude Barberis & Thierry Durroux. (2006) Probing the Existence of G Protein-Coupled Receptor Dimers by Positive and Negative Ligand-Dependent Cooperative Binding. Molecular Pharmacology 70:5, pages 1783-1791.
Crossref
Crossref